Author:
Fioretto Paola,Mauer Michael,Walsh Arthur W.,Elliott Michael D.,Chen Michael,Kaufman Dixon B.,Navarro Xavier,Kennedy William R.,Gaber A. Osama,Cashion Ann,Hathaway Donna,Shokouh-Amiri Hosein
Reference330 articles.
1. US Renal Data System. Annual Report. Washington, DC: National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases; 2000. 20.
2. Mauer M, Mogensen CE, Friedman EA. Diabetic nephropathy. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney. Boston: Little, Brown and Co., 2001: 2083–2127. 21.
3. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–1462. 22.
4. Lewis EJ, Hunsicker LG, Clarke WR, et al., For the Collaborative Study Group. Renoprotective effect of the angiotensinreceptor antagonist irbesartan in patients with nephropathy due 23. to type 2 diabetes. N Engl J Med 2001; 345: 851–860.
5. Brenner BM, Cooper ME, De Zeeuw D, et al., for the Renal Study Investigators. Effects of losartan on renal and cardiovas- 24. cular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–869.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献